Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Primary cutaneous B-cell lymphomas

J U Rijaarsdam¹, R Willemze

¹Department of Dermatology, Free University Hospital, Amsterdam, The Netherlands.

Leukemia & Lymphoma

|July 1, 1994

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Clear cell acanthoma on the dorsum of the hand.

Journal of the European Academy of Dermatology and Venereology : JEADV·2014

Same author

Diagnostic and prognostic significance of CDKN2A/CDKN2B deletions in patients with transformed mycosis fungoides and primary cutaneous CD30-positive lymphoproliferative disease.

The British journal of dermatology·2014

Same author

Clofarabine in combination with a standard remission induction regimen (cytosine arabinoside and idarubicin) in patients with previously untreated intermediate and bad-risk acute myelogenous leukemia (AML) or high-risk myelodysplastic syndrome (HR-MDS): phase I results of an ongoing phase I/II study of the leukemia groups of EORTC and GIMEMA (EORTC GIMEMA 06061/AML-14A trial).

Annals of hematology·2014

Same author

Expression of programmed death-1 in skin biopsies of benign inflammatory vs. lymphomatous erythroderma.

The British journal of dermatology·2014

Same author

Quantitation of tumour development correlates with prognosis in tumour stage (stage IIB) mycosis fungoides.

The British journal of dermatology·2013

Same author

Myeloablative T cell-depleted alloSCT with early sequential prophylactic donor lymphocyte infusion is an efficient and safe post-remission treatment for adult ALL.

Bone marrow transplantation·2013

Primary cutaneous B-cell lymphomas are skin-originating cancers distinct from node-based lymphomas. This review covers their clinical and histologic features, offering treatment guidelines for these specific lymphoma types.

Area of Science:

Dermatology
Hematology
Oncology

Background:

Primary cutaneous B-cell lymphomas (PCBCLs) are distinct from nodal lymphomas.
PCBCLs exhibit unique clinical behaviors and prognoses.
Key PCBCL subtypes include follicle center cell lymphomas, immunocytomas, and intravascular B-cell lymphomas.

Purpose of the Study:

To review the clinicopathologic features of primary cutaneous B-cell lymphomas.
To present treatment guidelines for recognized PCBCL entities.

Main Methods:

Literature review of primary cutaneous B-cell lymphomas.
Analysis of clinical and histologic characteristics.
Synthesis of current treatment recommendations.

Main Results:

Related Experiment Videos

Detailed description of primary cutaneous follicle center cell lymphomas, primary cutaneous immunocytomas, and cutaneous intravascular B-cell lymphomas.
Differentiation of PCBCLs from nodal B-cell lymphomas.
Established diagnostic criteria and prognostic factors.

Conclusions:

PCBCLs represent a unique group of non-Hodgkin lymphomas.
Accurate diagnosis based on clinicopathologic features is crucial.
Adherence to specific treatment guidelines improves patient outcomes.